Home > Products > CD3 & DLL3
> Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (scFv-CH1/CL)
Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-076)
Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD3 antibody variable domain is fused to CH1 and the other scFv from an anti-DLL3 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget T cells to tumor cells. It is designed for the research of Lung cancer; Pancreatic cancer; Skin cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (scFv-CH1/CL) (BSCC-076). Click the button below to contact us or submit your feedback about this product.